Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapy-Reference-Cited by-同舟云学术

Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapy

Published:2020-04-30 Issue:9 Volume:146 Page:2411-2417
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Zhang Yang,Deng Chaoqiang,Ma Xiao,Gao Zhendong,Wang Shengping,Zheng Qiang,Xia Guozhan,Wen Zhexu,Han Han,Fu Fangqiu,Liu Quan,Hu Hong,Li Yuan,Wong Kwok-Kin,Chen Haiquan^ORCID

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-020-03234-6.pdf

Reference19 articles.

1. Chang J et al (1999) Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer. J Clin Oncol 17:3058–3063. https://doi.org/10.1200/JCO.1999.17.10.3058

2. Demaria M et al (2017) Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov 7:165–176. https://doi.org/10.1158/2159-8290.CD-16-0241

3. Dooms C, Verbeken E, Stroobants S, Vansteenkiste J (2009) Biological correlates of the maximum 18-fluoro-2-deoxy-glucose uptake on positron emission tomography in non-small cell lung carcinoma after induction chemotherapy. J Thorac Oncol 4:1221–1225. https://doi.org/10.1097/JTO.0b013e3181ab0997

4. Eisenhauer EA et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247. https://doi.org/10.1016/j.ejca.2008.10.026

5. Geeleher P, Cox NJ, Huang RS (2014) Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines. Genome Biol 15:R47. https://doi.org/10.1186/gb-2014-15-3-r47

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multidimensional biological characteristics of ground glass nodules;Frontiers in Oncology;2024-05-22

2. The activity and immune dynamics of PD-1 inhibition on high-risk pulmonary ground glass opacity lesions: insights from a single-arm, phase II trial;Signal Transduction and Targeted Therapy;2024-04-19

3. Treatments and whole exon sequencing of a case with multiple primary lung cancer;Journal of Cardiothoracic Surgery;2023-02-02

4. Osimertinib showed efficacy on contralateral multiple ground-glass nodules after segmentectomy for lung adenocarcinoma harboring primary EGFR-T790M mutation: a case report and review of the literature;Journal of Cardiothoracic Surgery;2022-12-19

5. Treatments and whole exon sequencing of a case with multiple primary lung cancer;2022-11-14